ALMA LASERS™ RECEIVES FDA CLEARANCE FOR THE ACCENT™ DUAL MODE RF SYSTEM

BUFFALO GROVE, IL April 30, 2007 - Alma Lasers, a global leader in laser, light-based and radio frequency (RF) technologies used in aesthetic medicine, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Accent™ Dual Mode RF System in the United States.

Receiving its first FDA indication for the treatment of wrinkles and rhytids, the Accent system has been used successfully by medical professionals worldwide to treat a variety of dermatological and aesthetic conditions.

“We’re delighted to receive the marketing clearance for the Accent product in the United States,” stated Howard Kelly, CEO for Alma Lasers. “The unique dual mode RF modalities of the Accent system will provide physicians with the most advanced technology available in non-invasive aesthetic medicine; creating a higher standard in patient satisfaction. The company is committed to pursuing additional clearances from the FDA, in order to expand the clinical indications for the Accent system in the United States.”

Non-invasive, non-ablative and virtually pain free, the Accent system combines two radio frequency modes into one device. Each mode is delivered by a discrete handpiece to enable volumetric RF thermotherapy at different tissue depths within the body.

Ziv Karni, PhD, President and founder of Alma Lasers stated, “The Accent product was engineered for safety and ease of use, while maximizing efficacy. The continuous movement of either handpiece results in a gradual build-up of heat to achieve the optimal therapeutic effect, while providing greater patient comfort. With over one thousand Accent systems installed worldwide, the product has enjoyed an unparalleled safety record.”

“Non-invasive treatments are the largest and fastest growing category in aesthetic medicine,” said Yariv Matzliach, Executive Vice President of Global Marketing for Alma Lasers. “Now with its first FDA indication, the Accent system is poised to provide medical professionals and their patients in the United States with a new level of safety, efficacy and satisfaction in non-invasive treatments.”

“We have found the Accent system to be very safe and relatively comfortable with a high percentage of responders,” states David H. McDaniel, MD, Assistant Professor of Clinical Dermatology and Plastic Surgery, Eastern Virginia Medical School, Director of the Institute of Anti-Aging Research Center of Virginia, and a principal investigator in the FDA study. “Compared to other RF devices we have used, treatment with the Accent system is much less painful, faster and easier to perform. It also allows more ‘artistic’ use on the face. Although responses vary, a high percentage of treated subjects showed a visible response. Some observe an immediate skin tightening of the face.”

According to Maurice Sherman, MD, Associate Professor of Clinical Surgery, University of California – San Diego, and the owner of the Del Mar Cosmetic Medical Center in southern California, “We obtained remarkably good results with the Accent system. It was consistent for all of the patients that followed the protocol. All of them showed an improvement. Some dramatic, some moderate, but every patient expressed satisfaction with the results. Everyone said that their skin felt tighter the day after the first treatment.” Added Dr. Sherman, “Of all the RF systems on the market today, I feel the Accent is the most effective technology out there.”

About Alma Lasers
Alma Lasers is a global developer, manufacturer and marketer of laser, light-based and radio frequency devices for aesthetic applications.

The Company’s mission is to provide modular, cost-effective and high performance systems that enable medical practitioners to confidently offer safe, effective and profitable aesthetic treatments. More information about Alma Lasers can be found at www.almalasers.com.

Contact:
Yariv Matzliach, Executive Vice President, Global Marketing
866.414.2562
Yarivm@almalasers.com

FDA Attacks Complementary & Alternative Healthcare

PLEASE TAKE ACTION!

by John F. Gilbert, Ph.D. - President/NTCB

Please read and take action before April 30th. It is easy and takes 2 minutes. Pass this on to your friends and fellow practitioners. This proposal affects our right to choose our health care/practices. It is a witch hunt disguised as good medical practice.

I just spent three days reading, re-reading, researching and discussing the proposed FDA guidelines for “Complementary and Alternative Medicine” with two FDA attorneys. You can download a copy of this proposal for yourself at:
http://www.fda.gov/ohrms/dockets/dockets/06d0480/06d0480.htm .

When I first heard about this FDA attack on complementary and alternative health care, I considered it another “Chicken Little” rumor. On further study, I’m appalled at the speed with which the pharmaceutical companies are implementing Codex Alimentarius in the USA. If you don’t suspect the pharmaceutical companies control the FDA, you may want to research that further by visiting http://www.HealthFreedomUSA.org .

This insidious proposal is designed to redefine every complementary and alternative health care modality and product as “medicine.” This has direct implications on the services and products provided by every alternative health care professional. There is no facet of complementary and alternative health care that is not affected. If the FDA adopts this proposal, all natural health care would be illegal even for medical doctors.

Essential oils, herbs, herbal remedies, homeopathic remedies, minerals, nutritional supplements, plant enzymes and vitamins are redefined in this proposal as “medicine.” Very simply, medicine is under the jurisdiction of the FDA and, by law, only licensed medical doctors may prescribe “medicines.” Anybody else who advises, advocates, counsels, distributes, markets, recommends or suggests anybody use “medicine” is practicing medicine without a license. This is a felony in the USA punishable by fines and incarceration.

Aromatherapy, auricular therapy, biofeedback, color therapy, homeopathy, hypnotism, naturopathy, neurotherapy, nutritional consulting, reflexology, sound therapy and wellness consulting are among the alternative health modalities being redefined as “Alternative Medicine.” This subtle change of vocabulary from “alternative health care” to “alternative medicine” makes all of these industries subject to control by the FDA as medicine. Only medical doctors would be allowed to provide, prescribe and supervise the delivery of these services. Anybody else who provided any of these services would be practicing medicine without a license and subject to incarceration and fines.

That’s the bad news. The good news is we have until April 30, 2007 to voice our opinion against this proposal to eliminate complementary and alternative health care in America. Almost 100,000 people have already filed their objection. According to Dr. Rima Laibow, medical director of the Natural Therapies Foundation, we need 50 times that many people to respond by the end of the month.

Please stand up and be counted. Go to http://tinyurl.com/2u7ghc and file your petition in support of natural health care, in support of complementary and alternative health care as we know it today.

If you require more information, please visit http://www.HealthFreedomUSA.org or read the FDA proposed policy

Thank you!
John F. Gilbert, Ph.D. - President/NTCB

Plantogen Introduces Three Unique Green Tea Products

The Latest Trend in Anti-Oxidant Skin Therapy

(Australia) For centuries, Asian cultures have consumed a large amount of green tea and espoused its health properties. Studies have found that green tea is of significant importance in our quest to live longer and healthier lives. Green tea is nature’s strongest anti-oxidant possessing anti-inflammatory and anti-carcinogenic properties that have a profound impact on the skin. Studies have shown that we might benefit dramatically from the simple step of applying a form of green tea to our skin. Addition of green tea to our skin care regimen could have a dramatic effect on the number of skin cancer diagnosed each year. Additionally, green tea is powerful in slowing skin’s aging process.

Plantogen, plant derived spa therapy, has introduced three unique products for the face containing green tea which are structured to utilize its anti-oxidant properties to the fullest.

Intensive Firming Serum with Green Tea and Refirming Plant Extracts
An intensive firming serum with Green Tea (an anti oxidant) and an active standardized botanical complex of plant extracts, a combination of Lady’s Thistle, which is a free radical scavenger, Lady’s Mantle, Horsetail, Soy Germ, Wheat Germ, Alfalfa, and Radish extracts. Results in firmer, younger looking skin. It is a gel base so it encourages the active ingredients to be more readily absorbed into the skin. Ideal for use around the eyes especially around any fine lines.

Gentle Facial Scrub with Apricot, Jojoba and Green Tea
Gentle, foaming, exfoliating facial scrub, effective in sloughing dead skin cells to reveal a fresher, healthier looking skin. Helps to reduce surface oil while improving skin tone and texture. The exfoliating helps remove dead keratinized cells making the skin’s surface look smoother and clearer. The skin’s surface circulation and glow are improved. Cell renewal increases which in turn increases the efficiency of penetration of moisturisers applied after exfoliation, resulting in improved hydration of the skin’s surface. Many types of exfoliation can be very abrasive and can cause red, sensitive, thin skin. Consequently, Plantogen® Gentle Facial Scrub contains Jojoba beads with spherical and smooth shapes which are effective in exfoliating but are less irritating to the skin. Water soluble. Can be used for all skin types.

Hydrating Moisturizer with Manuka Honey and Vitamin C
An intensive hydrating moisturizer packed with plant extracts, vitamins and antioxidants in a liposomal solution to ensure targeted delivery. Contains natural Manuka Honey, Green Tea, Chamomile extracts and Vitamin E and Vitamin C, Wheat Germ Oil, Apricot Kernel Oil and Lecithin to help diminish fine lines, and reduce the signs of premature aging while relieving dryness. Skin feels, softer smoother and firmer.

Plantogen, plant derived spa therapy, combines pure plant extracts with scientific know how. Plant energy is powerful. The essence of health and beauty comes from within. We can make ourselves feel and look better by taking care of our bodies. Nurture yourself, relieve stress, respect your body and soul. Stay calm, be happy, drink lots of water .Our philosophy to skincare is this simple.

Plantogen
www.plantogen.com
800.851.6533

Plantogen Introduces Three Unique Green Tea Products

The Latest Trend in Anti-Oxidant Skin Therapy

(Australia) For centuries, Asian cultures have consumed a large amount of green tea and espoused its health properties. Studies have found that green tea is of significant importance in our quest to live longer and healthier lives. Green tea is nature’s strongest anti-oxidant possessing anti-inflammatory and anti-carcinogenic properties that have a profound impact on the skin. Studies have shown that we might benefit dramatically from the simple step of applying a form of green tea to our skin. Addition of green tea to our skin care regimen could have a dramatic effect on the number of skin cancer diagnosed each year. Additionally, green tea is powerful in slowing skin’s aging process.

Plantogen, plant derived spa therapy, has introduced three unique products for the face containing green tea which are structured to utilize its anti-oxidant properties to the fullest.

Intensive Firming Serum with Green Tea and Refirming Plant Extracts ($52.00/1.7oz.)
An intensive firming serum with Green Tea (an anti oxidant) and an active standardized botanical complex of plant extracts, a combination of Lady’s Thistle, which is a free radical scavenger, Lady’s Mantle, Horsetail, Soy Germ, Wheat Germ, Alfalfa, and Radish extracts. Results in firmer, younger looking skin. It is a gel base so it encourages the active ingredients to be more readily absorbed into the skin. Ideal for use around the eyes especially around any fine lines.

Gentle Facial Scrub with Apricot, Jojoba and Green Tea ($31.50/5.1oz.)
Gentle, foaming, exfoliating facial scrub, effective in sloughing dead skin cells to reveal a fresher, healthier looking skin. Helps to reduce surface oil while improving skin tone and texture. The exfoliating helps remove dead keratinized cells making the skin’s surface look smoother and clearer. The skin’s surface circulation and glow are improved. Cell renewal increases which in turn increases the efficiency of penetration of moisturisers applied after exfoliation, resulting in improved hydration of the skin’s surface. Many types of exfoliation can be very abrasive and can cause red, sensitive, thin skin. Consequently, Plantogen® Gentle Facial Scrub contains Jojoba beads with spherical and smooth shapes which are effective in exfoliating but are less irritating to the skin. Water soluble. Can be used for all skin types.

Hydrating Moisturizer with Manuka Honey and Vitamin C ($49.50/1.7oz.)
An intensive hydrating moisturizer packed with plant extracts, vitamins and antioxidants in a liposomal solution to ensure targeted delivery. Contains natural Manuka Honey, Green Tea, Chamomile extracts and Vitamin E and Vitamin C, Wheat Germ Oil, Apricot Kernel Oil and Lecithin to help diminish fine lines, and reduce the signs of premature aging while relieving dryness. Skin feels, softer smoother and firmer.

Plantogen, plant derived spa therapy, combines pure plant extracts with scientific know how. Plant energy is powerful. The essence of health and beauty comes from within. We can make ourselves feel and look better by taking care of our bodies. Nurture yourself, relieve stress, respect your body and soul. Stay calm, be happy, drink lots of water .Our philosophy to skincare is this simple.

Plantogen
www.plantogen.com
800.851.6533

Reliant Technologies Announces Groundbreaking Clinical Results For Deep Dermal Tissue Removal – A First Of Its Kind

First Round of Clinical Study Results of Fractional Deep Dermal Ablation (FDDATM) Treatment Presented at 27th ASLMS Annual Meeting

GRAPEVINE, TEXAS – Reliant Technologies, Inc., the market leader of fractional resurfacing, presented first phase results from a 230-patient multi-site clinical study of the new Fractional Deep Dermal Ablation (FDDA) treatment at the 27th American Society for Laser Medicine and Surgery (ASLMS) Annual Conference in Grapevine, Texas. The FDA-approved investigation is evaluating FDDA treatment for patients with severe photodamage including rhytids, skin laxity, acne scars, atrophic scars, vascular lesions and striae. The first round results, which were conducted utilizing the first prototypes of the Fraxel re:pairTM system, demonstrate that FDDA treatment is safe and effective without the extended recovery time and risks of adverse reactions associated with conventional ablative resurfacing lasers (also known as CO2 or erbium YAG lasers).

“Patients are often wary of CO2 lasers and surgical procedures because the post-treatment healing process can last as long as two weeks and disrupt their quality of life,” said Zakia Rahman, M.D., clinical instructor of dermatology at Stanford University in Palo Alto, CA, and medical director of the Fraxel® Laser Clinic. “These study results indicate that by combining fractional and ablative technologies, FDDA treatment may be a new treatment paradigm in the skin resurfacing arena, providing dramatic results that patients and physicians want without significant risks.”

Dr. Rahman will present the first round results of a 30-patient study from three investigational sites, which examined FDDA treatment for patients with severe photodamage, including rhytids and skin laxity. The results demonstrate that patients treated with the prototype Fraxel re:pair system sustained significant improvements through the final follow-up visit. More than 75 percent of patients experienced improved appearance of rhytides and pigmentation as well as skin laxity, while no adverse effects were observed.

FDDA treatment combines the benefits of conventional CO2 resurfacing with the safety of fractional photothermolysis. In contrast to conventional bulk ablative laser skin resurfacing where 100 percent of the epidermis is ablated leaving only superficially coagulated dermis, the Fraxel re:pair system treats to depths exceeding 1.6 mm. The ability to uniformly remove deep dermal tissue constitutes an entirely new paradigm. The Fraxel re:pair system induces ablation, followed subsequently by tissue contraction, tightening and collagen remodeling. The result is a multi-dimensional approach for treatment of photodamage which relies on a broader range of mechanisms than those employed with surgical procedures.

“Reliant is committed to ensuring that physicians have the most advanced treatments to offer their patients that don’t compromise safety or patient quality of life,” said Len DeBenedictis, chief technology officer of Reliant Technologies. “We continue to invest in research and clinical testing to expand the Fraxel product line to address the serious skin conditions that patients most want repaired, including skin laxity, severe photodamage, vascular lesions and wrinkles. We are excited to share at ASLMS the findings of our multi-center study of FDDA treatment performed by 10 of the industry’s leading physician investigators.”

Clinical presentations about FDDA treatment being presented at the 27th ASLMS Annual Meeting include:

• The study titled, “Ablative Fractional Resurfacing for the Treatment of Photodamge and Laxity,” will be presented by Zakia Rahman, M.D., F.A.A.D from Stanford University on Friday, April 13, 2007 at 1:05 p.m.
• The study titled, “Fractional Carbon Dioxide Laser Resurfacing of Photodamage and Acne Scars,” will be presented by Elizabeth K. Hale, MD, Roy G. Geronemus, MD, et al. of the Laser & Skin Surgery Center of New York, on Friday, April 13, 2007 from 5:41 p.m. - 5:46 p.m.
• The study titled, “Fractional Deep Dermal Ablation,” with be presented by Christopher B. Zachary, MB.BS., FRCP of the University of California Irvine on Saturday, April 14, 2007 at 7:00 am.
• The poster presentation titled, “Report of a Novel Fractional Ablative Laser for Tissue Tightening,” will be presented by Dr. Rahman on Saturday, April 14, 2007 from 5:00 p.m. - 7:30 pm.
• The study titled, “Why Fractional? Why Ablative? Why Deep?” will be presented by Christopher B. Zachary, MBBS, FRCP of the University of California Irvine at 7:00 am on Sunday, April 15.

About the Fraxel Systems and Reliant Technologies
Reliant Technologies develops clinical solutions to repair and rejuvenate aging and environmentally damaged skin. Reliant is dedicated to providing the most advanced research, engineering and products to the global aesthetic marketplace. The company pioneered the development of fractional laser resurfacing which relies on novel high speed scanning systems and the Intelligent Optical Tracking® system to produce safe and effective results with minimal recovery time. The Fraxel family of products has quickly become the industry standard for aesthetic laser skin treatment. Because of their gentle, non-invasive approach to skin resurfacing, Fraxel lasers are used primarily by aesthetic physicians to treat periorbital wrinkles, pigmented lesions, acne scars and surgical scars. Fraxel lasers have received multiple FDA clearances and have been found safe and effective in treating all skin types and all areas of the face and body. Reliant is headquartered in Mountain View, California. For more

Reliant Technologies
www.fraxel.com
888.4FRAXEL (437.2935)

Creating the Rodeo Drive Look
Although word has it TV’s Nip/Tuck is headed for Rodeo Drive, in the real world, Rodeo Drive Plastic Surgery is the first and only plastic surgery center on Beverly Hills’ ultimate address. Lloyd Krieger, M.D., founder and Medical Director of the center, who has been featured in such media as Fortune, The New York Times, the Wall Street Journal, Access Hollywood and other media, is known both as an artist and an innovator in the world of plastic surgery.

The Rodeo Drive Chin Rejuvenation™
Perhaps best known for his Rodeo Drive Mommy Makeover™, created for women who want their stomachs and breasts to look the way they did before their pregnancy, Dr. Krieger now introduces the Rodeo Drive Chin Rejuvenation™, a transformational minimally-invasive plastic surgery procedure, ideal for patients who (no matter how much they exercise or how much weight they lose) are tired of seeing that double chin staring back at them in the mirror.

The Rodeo Drive Chin Rejuvenation™ is a unique form of facial rejuvenation, a chin and neck liposuction procedure that does not take a long time in the operating room or have a prolonged recovery period. Despite its minimally invasive nature, this cosmetic surgery can make a dramatic change in a person’s appearance. In the past, patients would need a facelift or necklift to correct the problem of excess fat under the chin and in the neck. But, for appropriate candidates, this procedure is effective, has little downtime and successfully addresses the problem of the annoying “double chin” or overly full-looking neck. The Rodeo Drive Chin Rejuvenation™, which is ideal for both men and women, can dramatically improve a person’s appearance with minimal downtime and less risk of scarring. Compared with the routine facelift or necklift, Dr. Krieger’s procedure is less expensive, easier to recover from, affords minimal recovery time and can have remarkable benefits for the ideal candidate.

Rodeo Drive Plastic Surgery is Beverly Hills’ most elegant of medical facilities, featuring state-of-the-art exam rooms, marble counter tops, bamboo floors, and leather chairs. Dr. Krieger completed his education at Stanford University and the University of Chicago. He completed his residency at UCLA and maintains operating privileges at UCLA and Cedars-Sinai medical centers.

Rodeo Drive Plastic Surgery
www.rodeodriveplasticsurgery.com
310. 550.6300

ULTRASHAPE® CONTOUR I FEATURED IN ASAPS HOT TOPICS PANEL, “EMERGING TECHNOLOGY IN PLASTIC SURGERY”

UltraShape CONTOUR I to be Included in Four Presentations
at the Aesthetic Meeting 2007

YOQNEUM, Israel and SAN RAMON, California – The UltraShape CONTOUR I, the first clinically proven non-invasive solution for body contouring based on focused ultrasound technology, will be featured in the Hot Topics panel “Emerging Technology in Plastic Surgery” at the Aesthetic Meeting 2007, the annual meeting for The American Society of Plastic Surgery (ASAPS) and The Aesthetic Surgery Education and Research Foundation (ASERF). The presentation, “Non-Invasive Lipolsysis by External Focused UltraSound (UltraShape CONTOUR I),” will be presented by plastic surgeon Dr. Benjamin Ascher.

“This year UltraShape’s clinical findings are not only included in the highly-watched Hot Topics panel, but also featured in three additional scientific and clinical presentations, which demonstrates continued clinical success and global market adoption of the technology,” explained Rodger Stewart, President and Chief Executive Officer of UltraShape Inc. “Furthermore, Dr. Ascher’s results are consistent with the commercial experience that many physicians outside the United States have seen performing the UltraShape® procedure in their practices.”

Hot Topics
Ascher was selected to present on his extensive experience using the UltraShape CONTOUR I in his plastic surgery practice in Paris, France. His data following three treatments at three week intervals demonstrated that 92% of his patients experienced measurable circumference reduction. In addition, 88% of patients expressed satisfaction with their results. Ascher noted the importance of appropriate patient selection and setting the right expectations.

“Through my own studies I have seen that most of the patients not only respond well to the treatment, but also express great satisfaction due to the convenience of the ‘walk-in, walk-out’ session and no requirements for maintenance treatments,” explained Ascher. ”I have found that the UltraShape CONTOUR I system is an effective non-invasive body contouring solution for the abdomen, flanks and thighs and could possibly be considered an alternative to conventional liposuction for the appropriate candidates.”

Dr. Ascher is a leading plastic surgeon specializing in plastic, aesthetic and reconstructive surgery and body contouring. He is a member of the French Society of Plastic, Aesthetic and Reconstructive Surgery (SOFPRE). He is the Scientific Director of IMCAS Congresses, International Master Courses on Aging Skin and teacher leader in Europe for Plastic Surgeons and Cosmetic Dermatologists.

Additional Presentations at ASAPS Highlighting UltraShape
In addition to the Hot Topics panel, UltraShape will be featured in the following presentations:

Friday, April 20, 2007 – Advances in Minimally Invasive Face & Body Rejuvenation Featuring Live Patient Demonstrations: “Non-Surgical Fat Removal” By: Jeffrey M. Kenkel, M.D., Professor and Vice Chairman of the Department of Plastic Surgery at the University of Texas Southwestern Medical Center at Dallas and Chairman, UltraShape North America Medical Advisory Board.

Sunday, April 22, 2007 – Ancillary Light, Radiofrequency, Ultrasound, and Wire-Release Procedures in Your Practice: “Introduction and Review of Clinical Studies to Date of Non-Invasive Body Contouring using UltraShape” By: Gordon Sasaki, M.D., Clinical Professor of Plastic Surgery at Loma Linda University Medical School.

Tuesday, April 24, 2007 – Minimally Invasive Body Contouring Surgery: “Non-Invasive Body Contouring With Focused Ultrasound Using UltraShape CONTOUR I” By: Steven Teitelbaum, M.D., Assistant Clinical Professor of Plastic Surgery at the David Geffen School of Medicine at UCLA, Medical Director of the Santa Monica Institute of Laser and Esthetic Surgery, Member, UltraShape North America Medical Advisory Board, and Principal Clinical Investigator in UltraShape’s completed and published multi-center worldwide controlled clinical study.

“These presentations further conclude that the UltraShape CONTOUR I has been scientifically demonstrated to produce definitive, measurable circumference and fat thickness reduction without pain or downtime. It has also been shown to selectively target and disrupt fat without harming surrounding tissues,“ said Kenkel.

About the UltraShape CONTOUR I
The UltraShape CONTOUR I system, based on patented focused ultrasound technology, is the first clinically proven non-invasive body contouring solution for both men and women. It is designed to target and disrupt fat, leaving surrounding structures such as skin, blood vessels, and nerves intact. The UltraShape procedure is guided by proprietary real-time tracking and guidance software designed to deliver smooth, uniform body contouring results. The software guarantees adherence to a pre-determined treatment algorithm minimizing risk of contour irregularities, a common side effect of liposuction which is a highly technique-sensitive surgical procedure.

The UltraShape procedure is performed during a convenient, “walk-in, walk-out” session carried out in an office-based environment; it requires no anesthesia or sedation, and the vast majority of patients report no pain or discomfort. After treatment, patients immediately resume their daily routines and there is no need for maintenance treatments. The UltraShape CONTOUR I system received the CE Mark in June 2005 and is currently distributed in 45 countries outside of the United States. Over 30,000 commercial treatments have been performed worldwide with high patient satisfaction.

About UltraShape
UltraShape Inc., founded in 2000, is a privately held and venture backed company that develops, manufactures and markets innovative, non-invasive solutions for the aesthetic medical field. The UltraShape expert team is dedicated to the development of cutting-edge body-contouring technology in a mission to enhance patients’ self-image and sense of well-being. The UltraShape CONTOUR I, the first clinically proven non-invasive body contouring solution based on focused ultrasound technology, received the CE Mark in June 2005 and is currently distributed in 45 countries outside the United States. Over 30,000 commercial treatments have been performed to-date.

The concept behind the company’s platform technology was developed by Ami Glicksman, M.D., a plastic surgeon and Yoram Eshel, Ph.D., MBA, a medical physicist who teamed up to marry the aesthetic clinical experience of the doctor and the expertise in high power focused ultrasound of the physicist.

UltraShape adheres to the highest scientific and quality standards and is ISO 13485: 2003 certified. The company has worldwide offices in the United States, Israel, France, United Kingdom, and Italy. The UltraShape CONTOUR I system is not cleared by the FDA for marketing in the United States.

UltraShape Inc.
www.ultrashape.com
925.242.2585

Chandler Chicco – A Healthcare Agency Worth Hearing About

Twelve years ago, two healthcare public relations veterans walked away from prestigious posts at a leading healthcare PR agency to pursue a dream. Since that time, Bob Chandler and Gianfranco Chicco have proven that it’s possible to build an agency that exists for one purpose and one purpose only: to provide healthcare clients with the smartest, fastest, most creative counsel available—without the limitations and constraints that often tie the hands of traditional PR agencies.

In its early days, Chandler Chicco Agency (CCA) received a great deal of attention for the seemingly superficial things which made it stand out from its competitors: its wide-open downtown office without walls, lack of titles and hierarchy, and its emphasis on team rather than star performances ― a vast difference from the Madison Avenue standard.

Today, it is the success that CCA has helped its clients achieve throughout the years that has enabled it to become the largest independent healthcare agency in the world – the company PRWeek most recently named PR Agency of the Year and The Holmes Report named Healthcare Agency of the Year and in years past was also named Specialist Agency of the Year, Creative Agency of the Year, and Europe’s Healthcare Consultancy of the Year by The Holmes Report.

Whether we’re working on the launch of BOTOX® for hyperhidrosis or PREVAGE® antioxidant cream; managing issues for BOTOX Cosmetic, Viagra, Baytril or Rezulin; or crafting the reorganization of Bayer Biologicals, we spend a tremendous amount of time assessing our clients’ business needs from all vantage points. We develop solutions that are creative, but always meaningful, and flawlessly deliver results without over-promise or hype. And because of our unique work environment, the focus always remains steadfastly on the work and involves creative minds at every level of experience.

The majority of CCA business is global with operations in New York, London, Washington, Los Angeles and Paris, supported by a pure-play global affiliate network spanning nearly 20 countries. The CCA team, more than 200 healthcare communications specialists who have collective experience in virtually every therapeutic category, offers counsel and services across a multitude of disciplines.

But it is not solely our array of services that continues to attract such clients as Novartis, Sanofi-Aventis, Bristol- Myers Squibb, GlaxoSmithKline and Roche. Rather, these clients come to – and remain with – Chandler Chicco Agency because they are confident that when they give CCA a piece of business, they are adding talent to their corporate teams. Each client quickly learns that CCA is not just another agency, but rather an extension of the product team and company they are supporting.

Chandler Chicco Agency - Core Capabilities

• Communications Counsel
• Corporate Positioning
• Message Development and Training
• Marketing Communications
• Media Relations
• Disease Awareness Campaigns
• Advocacy Relations
• Medical Education
• Clinical Trial Recruitment
• Global Health Policy and Public Affairs
• Issues / Crisis Management

Chandler Chicco Agency
www.ccapr.com
310.309.1000

Cynosure Participates at ASLMS with Nine Technical and Clinical Presentations

WESTFORD, Mass., Cynosure, Inc. (Nasdaq: CYNO) announced today that its newest aesthetic laser systems was the subject of nine technical and clinical presentations at Laser 2007, the 27th Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS). The five-day conference, spotlighted the latest breakthroughs in laser technologies for diagnostics, basic science and clinical treatments at the Gaylord Texan Resort and Convention Center in Grapevine, Texas.

“Our collaboration with industry luminaries on research initiatives such as those being presented at the ASLMS Conference reinforces the benefits of our newest flagship products for a broad range of applications,” said Cynosure President and CEO Michael Davin. “The key message for physicians and other medical professionals who attend the conference is that Cynosure is a leader not only in technology innovation but in working with them to help to profitably build their aesthetic laser practices.”
Laser 2007 will include the presentation of analytical data from studies involving Cynosure’s Affirm(TM) Anti-Aging Workstation, Smartlipo(TM) LaserBodySculpting Workstation and Cynergy(TM) Vascular Workstation. The schedule is as follows:
Affirm Anti-Aging Workstation

* “My approach to periocular rejuvenation,” Brian S. Biesman, M.D., Nashville, Tenn., 12:15 to 1:15 p.m. Thursday, April 12.

* “Affirm and Fraxel Laser Skin Resurfacing: A side-by-side study,” Sherry Collawn, M.D., Mountain Brook Plastic Surgery, Birmingham, Ala., 5:00 to 7:30 p.m. Friday, April 13.

* “Multicenter study of Microthermal Laser Treatment of Acne Scars,” Emil Tanghetti, M.D. Center for Dermatology and Laser Surgery, Sacramento, Calif., and Robert Weiss, M.D., Maryland Laser, Skin and Vein Institute, Hunt Valley, Md., 11:23 to 11:30 a.m. Sunday, April 15.

Smartlipo LaserBodySculpting Workstation

* Pre-Conference Course on Skin Rejuvenation, Bruce Katz, M.D., Clinical Professor, Mt. Sinai School of Medicine, and Director of the Juva Skin and Laser Center, 8 a.m. to noon Thursday, April 12. The course will be directed by Roy Geronemus, M.D., Laser & Skin Surgery Center of New York.

Cynergy Vascular Workstation

* “Residence Time of Methemoglobin in Dual Wavelength Laser Therapy of Portwine Stains,” Wim Verkruysse, M.D., Beckman Laser Institute and Medical Clinic, University of California, Irvine, 2:15 to 2:27 p.m. Friday, April 13.

* “The Combination of Pulsed Dye and Nd:YAG Lasers in Treatment of Nodular and Thick Portwine Stains,” Ashraf Badawi, M.D., Laser Institute, Cairo University, Cairo, Egypt, 1:48 to 1:55 p.m. Saturday, April 14.

* “Treating Facial Telangiectasia with a Dual Wavelength Laser System (595 nm and 1064 nm): A Split-Face Trial with Blinded Response Evaluation,” Christian Raulin, M.D., Laserklinik Karlsruhe, Germany, 1:55 to 2:20 p.m. Saturday, April 14.

* “Multicenter Evaluation of Cynergy MultiPlex Laser Treatment of Leg Veins,” Emil Tanghetti, M.D., and Robert Adrian, M.D., Centers for Laser Surgery, Washington, D.C., 2:02 to 2:09 p.m. Saturday, April 14.

* “A Single Center, Randomized, Prospective Clinical Study to Determine the Efficacy of the Cynergy Laser in the Treatment of Photoaging: Split Face Study,” Jane G. Khoury, Pavan K. Nootheti, Mitchel P. Goldman, Dermatology/Cosmetic Laser Associates of La Jolla, Inc., La Jolla, Calif., 8:57 to 9:04 a.m. Sunday, April 15.
The American Society for Laser Medicine and Surgery (ASLMS) is the world’s preeminent resource for laser research, safety, education, and clinical knowledge. Founded in 1980, ASLMS promotes excellence in patient care by advancing clinical application of lasers and related technologies. For more information and physician referrals, please visit the Society’s website: http://www.aslms.org.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure’s products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

Cynosure, Inc.
www.cynosurelaser.com
800.886.2966

Introducing ArteFill®, First and Only FDA Approved
Permanent Dermal Filler for Facial Wrinkles

The Food and Drug Administration (FDA) has approved ArteFill®, the first and only PERMANENT dermal filler on the market today for the correction of facial lines and wrinkles. ArteFill® has finally been made available to select board certified plastic surgeons and has been gaining a considerable amount of praise and popularity throughout the medical community.

Dr. Allen D. Rosen , board certified plastic surgeon, spokesperson for the American Society of Plastic Surgeons and Medical Director of The Plastic Surgery Group in Montclair, NJ, has acquired ArteFill® for his patients and finds that it is the optimum solution for those who experience “injection fatigue” that may occur with temporary fillers.

ArteFill® is a dual-acting non-resorbable injectable filler which is comprised of 80% bovine collagen (absorbed by the body) and 20% patented microspheres which are not absorbed by the body. These unique microspheres are made of the same material which has been used in dozens of medical implants for craniofacial and orthopedic surgery for over 50 years. According to Dr. Rosen, “The collagen in ArteFill® is absorbed by the body, while the microscopic level spheres stay at the site of the injection and form scar tissue which simulates an implant.” This permanent support enables the correction of lines and wrinkles and prevents further wrinkling from occurring.

ArteFill® patients require only one or two treatments, and are a great adjunct to temporary fillers which require repeat injections every 6 to 9 months. Results are seen immediately and there is no downtime.

Rosen adds, “First time ArteFill® patients are required to have a collagen skin test prior to injection as a safety precaution to make sure that the patient is not allergic to bovine collagen.” His partner, Dr. Valerie Ablaza concurs, stating” Artefill really fills the gap for patients who want fillers that last.”

A recently completed five-year study of patients treated with ArteFill® showed statistically significant improvement in patient wrinkle correction five years after the patient’s last ArteFill® treatment. Over 90% of the physician assessments were completely successful.

Artes Medical
www.artefill.com
858.550.9999